86 related articles for article (PubMed ID: 23017432)
1. Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative.
Chanda D; Bhushan S; Guru SK; Shanker K; Wani ZA; Rah BA; Luqman S; Mondhe DM; Pal A; Negi AS
Eur J Pharm Sci; 2012 Dec; 47(5):988-95. PubMed ID: 23017432
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule.
Singh A; Fatima K; Singh A; Behl A; Mintoo MJ; Hasanain M; Ashraf R; Luqman S; Shanker K; Mondhe DM; Sarkar J; Chanda D; Negi AS
Eur J Pharm Sci; 2015 Aug; 76():57-67. PubMed ID: 25933717
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer.
Singh A; Fatima K; Srivastava A; Khwaja S; Priya D; Singh A; Mahajan G; Alam S; Saxena AK; Mondhe DM; Luqman S; Chanda D; Khan F; Negi AS
Chem Biol Drug Des; 2016 Nov; 88(5):625-634. PubMed ID: 27495835
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated benzylidene indanone exhibits antiproliferative activity through modulation of microtubule dynamics and antiangiogenic activity.
Srivastava A; Fatima K; Fatima E; Singh A; Singh A; Shukla A; Luqman S; Shanker K; Chanda D; Khan F; Negi AS
Eur J Pharm Sci; 2020 Nov; 154():105513. PubMed ID: 32805425
[TBL] [Abstract][Full Text] [Related]
5. Gallic acid based steroidal phenstatin analogues for selective targeting of breast cancer cells through inhibiting tubulin polymerization.
Parihar S; Gupta A; Chaturvedi AK; Agarwal J; Luqman S; Changkija B; Manohar M; Chanda D; Chanotiya CS; Shanker K; Dwivedi A; Konwar R; Negi AS
Steroids; 2012 Jul; 77(8-9):878-86. PubMed ID: 22503714
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
[TBL] [Abstract][Full Text] [Related]
7. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
8. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
9. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
10. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
12. In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatine.
Ghosh M; Talukdar D; Ghosh S; Bhattacharyya N; Ray M; Ray S
Toxicol Appl Pharmacol; 2006 Apr; 212(1):45-58. PubMed ID: 16112157
[TBL] [Abstract][Full Text] [Related]
13. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
Newman SP; Foster PA; Stengel C; Day JM; Ho YT; Judde JG; Lassalle M; Prevost G; Leese MP; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Jan; 14(2):597-606. PubMed ID: 18223236
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of nitrovinyl biphenyls: anticancer agents based on allocolchicines.
Jain N; Yada D; Shaik TB; Vasantha G; Reddy PS; Kalivendi SV; Sreedhar B
ChemMedChem; 2011 May; 6(5):859-68. PubMed ID: 21472861
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.
Ferreira AK; Meneguelo R; Pereira A; Mendonça Filho O; Chierice GO; Maria DA
Anticancer Res; 2012 Jan; 32(1):95-104. PubMed ID: 22213293
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer.
Yang J; Ahn S; Wu Z; Hwang DJ; Miller DD; Dalton JT
Int J Oncol; 2012 Jul; 41(1):337-44. PubMed ID: 22576690
[TBL] [Abstract][Full Text] [Related]
20. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
